In contrast, the decreased activity of Notch1 in the cancer cells resulted in additivity with a tendency towards antagonism, which means that a high dose of two-drug mixture is required to reach the same effect (50% inhibition of proliferation). The gene discussed is NOTCH1; the disease is cancer.